Neuronetics (STIM) EBITDA Margin Growth (5y) (2022 - 2026)
Powered by 
Analysis
Neuronetics (STIM) EBITDA Margin Growth (5y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.63 Bn | 178.03 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn |
| 3 | Medtronic | 118.51 Bn | 109.69 Bn | 6.34 Bn |
| 4 | Stryker | 106.53 Bn | 103.06 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.52 Bn | 65.98 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.57 Bn | 45.32 Bn | 1.35 Bn |
| 7 | Alcon | 34.00 Bn | 32.55 Bn | 1.68 Bn |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn |
| 9 | Steris | 21.12 Bn | 20.64 Bn | 684.20 Mn |
| 10 | Neuronetics | 223.41 Mn | 203.98 Mn | 21.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,260.00 |
| Mar 31, 2026 | 3,012.00 |
| Dec 31, 2025 | 500.00 |
| Sep 30, 2025 | -16.00 |
| Jun 30, 2025 | 4,927.00 |
| Mar 31, 2025 | 5,588.00 |
| Dec 31, 2024 | -1,102.00 |
| Sep 30, 2024 | -216.00 |
| Jun 30, 2024 | -1,185.00 |
| Mar 31, 2024 | 1,606.00 |
| Dec 31, 2023 | 1,441.00 |
| Sep 30, 2023 | -1,807.00 |
| Jun 30, 2023 | -222.00 |
| Mar 31, 2023 | -1,839.00 |
| Dec 31, 2022 | -750.00 |
| Sep 30, 2022 | -1,840.00 |
| Jun 30, 2022 | -3,499.00 |
| Mar 31, 2022 | -1,848.00 |